Researchers have developed a machine learning model that predicts Cas9 proteins that can be tailored with designer properties for therapeutic use.

Gene therapy developer CRISPR Therapeutics AG (CRSP) is navigating some regulatory and commercial dynamics. Its flagship gene ...

Biomedical Research leads at USD 1.5 billion, supporting genetic discovery and translational research.

It sounds like science fiction—but with CRISPR gene editing and ancient DNA research advancing rapidly, the idea of bringing ...

Oct. 28, 2024 — Using state-of-the-art technology, researchers have identified several specific steps needed for CRISPR to become active and perform its gene editing ... Single-Dose Gene Therapy ...

Learn about Brink Therapeutics as it raises $4 million to go beyond CRISPR with engineered recombinases in CAR T therapy.

Colossal Laboratories & Biosciences claimed they had resurrected the long-extinct Ice Age dire wolf using gene editing ...

The global gene therapy market is projected to grow at a significant CAGR of 20% from 2024 to 2029. This growth is driven by ...

This webinar will provide an overview of clustered regularly interspaced short palindromic repeats (CRISPR) prime editing, a groundbreaking genome-editing technology that offers unprecedented accuracy ...

A phase 1/2 trial of CRISPR-engineered eTIL therapy KSQ-004EX for advanced solid tumors has dosed its first patient.

Gene editing technologies have cemented their place as a valued method in the biological toolkit used by researchers around the globe.